Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing

Glioblastoma (GBM) is one of the most aggressive cancers due to its high mortality rate in spite of intensive treatment. It may be happened because of drug resistance against their typical receptors, since these receptor genes are often mutated by environmental stress. So identifying mutated oncodri...

Full description

Saved in:
Bibliographic Details
Main Authors: Arnob Sarker, Burhan Uddin, Reaz Ahmmed, Sabkat Mahmud, Alvira Ajadee, Md. Al Amin Pappu, Md. Abdul Aziz, Md. Nurul Haque Mollah
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025004323
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573111567908864
author Arnob Sarker
Burhan Uddin
Reaz Ahmmed
Sabkat Mahmud
Alvira Ajadee
Md. Al Amin Pappu
Md. Abdul Aziz
Md. Nurul Haque Mollah
author_facet Arnob Sarker
Burhan Uddin
Reaz Ahmmed
Sabkat Mahmud
Alvira Ajadee
Md. Al Amin Pappu
Md. Abdul Aziz
Md. Nurul Haque Mollah
author_sort Arnob Sarker
collection DOAJ
description Glioblastoma (GBM) is one of the most aggressive cancers due to its high mortality rate in spite of intensive treatment. It may be happened because of drug resistance against their typical receptors, since these receptor genes are often mutated by environmental stress. So identifying mutated oncodriver genes which could be used as potential drug target is essential in order to develop effective new therapeutic drugs as well as better prognosis for GBM patients. In this study, we analyzed whole exome sequencing (WES) profiles of NCBI database on GBM and matched-normal (control) samples originated from astrocyte like neural stem cells (NSC) of subventricular zone (SVZ) to explore GBM-causing mutated oncodriver genes, since SVZ is considered as the origin of GBM development. We detected 16 mutated oncodriver genes. Then, filtering by differential co-expression analysis based on independent RNA-Seq profiles of CGGA database revealed 10 genes as dysregulated oncodriver genes. Following that, 3 significantly overexpressed oncodriver genes (MTCH2, VWF, and WDR89) were identified as potential drug targets. Then molecular mechanisms of GBM development were investigated by these three overexpressed driver genes through gene ontology (GO), KEGG-pathways, Gene regulatory network (GRN) and mutation analysis. Finally, overexpressed oncodriver genes guided top-ranked six drug agents (Irinotecan, Imatinib, etoposide, pazopanib, trametinib and cabozanitinib) were recommended against GBM through molecular docking study. Most of our findings received support by the literature review also. Therefore, the findings of this study might carry potential values to the wet-lab researchers for further investigation in terms of diagnosis and therapies of GBM.
format Article
id doaj-art-db97678e9664421f9d18664d354950d4
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-db97678e9664421f9d18664d354950d42025-02-02T05:28:53ZengElsevierHeliyon2405-84402025-01-01112e42052Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposingArnob Sarker0Burhan Uddin1Reaz Ahmmed2Sabkat Mahmud3Alvira Ajadee4Md. Al Amin Pappu5Md. Abdul Aziz6Md. Nurul Haque Mollah7Bioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, Bangladesh; Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, BangladeshBioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, Bangladesh; Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, BangladeshBioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, Bangladesh; Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, BangladeshBioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, BangladeshBioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, BangladeshBioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, BangladeshDepartment of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, 6205, BangladeshBioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, 6205, Bangladesh; Corresponding author.Glioblastoma (GBM) is one of the most aggressive cancers due to its high mortality rate in spite of intensive treatment. It may be happened because of drug resistance against their typical receptors, since these receptor genes are often mutated by environmental stress. So identifying mutated oncodriver genes which could be used as potential drug target is essential in order to develop effective new therapeutic drugs as well as better prognosis for GBM patients. In this study, we analyzed whole exome sequencing (WES) profiles of NCBI database on GBM and matched-normal (control) samples originated from astrocyte like neural stem cells (NSC) of subventricular zone (SVZ) to explore GBM-causing mutated oncodriver genes, since SVZ is considered as the origin of GBM development. We detected 16 mutated oncodriver genes. Then, filtering by differential co-expression analysis based on independent RNA-Seq profiles of CGGA database revealed 10 genes as dysregulated oncodriver genes. Following that, 3 significantly overexpressed oncodriver genes (MTCH2, VWF, and WDR89) were identified as potential drug targets. Then molecular mechanisms of GBM development were investigated by these three overexpressed driver genes through gene ontology (GO), KEGG-pathways, Gene regulatory network (GRN) and mutation analysis. Finally, overexpressed oncodriver genes guided top-ranked six drug agents (Irinotecan, Imatinib, etoposide, pazopanib, trametinib and cabozanitinib) were recommended against GBM through molecular docking study. Most of our findings received support by the literature review also. Therefore, the findings of this study might carry potential values to the wet-lab researchers for further investigation in terms of diagnosis and therapies of GBM.http://www.sciencedirect.com/science/article/pii/S2405844025004323Glioblastoma (GBM)Whole exome Sequence (WES) profileSomatic mutationOncodriver genesDrug repurposingIntegrated bioinformatics analysis
spellingShingle Arnob Sarker
Burhan Uddin
Reaz Ahmmed
Sabkat Mahmud
Alvira Ajadee
Md. Al Amin Pappu
Md. Abdul Aziz
Md. Nurul Haque Mollah
Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
Heliyon
Glioblastoma (GBM)
Whole exome Sequence (WES) profile
Somatic mutation
Oncodriver genes
Drug repurposing
Integrated bioinformatics analysis
title Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
title_full Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
title_fullStr Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
title_full_unstemmed Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
title_short Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing
title_sort discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis and drug repurposing
topic Glioblastoma (GBM)
Whole exome Sequence (WES) profile
Somatic mutation
Oncodriver genes
Drug repurposing
Integrated bioinformatics analysis
url http://www.sciencedirect.com/science/article/pii/S2405844025004323
work_keys_str_mv AT arnobsarker discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT burhanuddin discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT reazahmmed discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT sabkatmahmud discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT alviraajadee discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT mdalaminpappu discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT mdabdulaziz discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing
AT mdnurulhaquemollah discoveryofmutatedoncodrivergenesassociatedwithglioblastomaoriginatedfromstemcellsofsubventricularzonethroughwholeexomesequenceprofileanalysisanddrugrepurposing